Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma, Lobular × entrectinib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 4 Neoplasm Metastasis 3 Hematologic Neoplasms 3 Breast Neoplasms 3 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Leukemia, Myeloid, Acute 2 Uveal Melanoma 1 Thrombocytosis 1 Sarcoma 1 Rare Tumour 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Noonan Syndrome 6 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Melanoma 1 Lymphoproliferative Disorders 1 Lymphoma, Non-Hodgkin 1 Locally Advanced Thyroid Gland Carcinoma 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Accelerated Phase 1

Interventions

Radiotherapy 4 Chemotherapy, Adjuvant 3 Trastuzumab 2 Magnetic Resonance Spectroscopy 2 Letrozole 2 Fulvestrant 2 Cyclophosphamide 2 Carboplatin 2 repotrectinib 1 proto-oncogene protein c-fes-fps 1 palbociclib 1 neratinib 1 gallium 68 PSMA-11 1 fluciclovine F-18 1 entrectinib 1 Zolpidem 1 Vinorelbine 1 Venlafaxine Hydrochloride 1 Thiotepa 1 Tamoxifen 1 Sugars 1 Sampling Studies 1 Reverse Transcriptase Polymerase Chain Reaction 1 Radiotherapy, Conformal 1 Radiomics 1 Radiation 1 Proton Therapy 1 Positron Emission Tomography Computed Tomography 1 Paclitaxel 1 Neoadjuvant Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04551495 2024-12-04

ROSALINE

Jules Bordet Institute

Phase 2 Active not recruiting

Carcinoma, Lobular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡